Related Experiment Video
Updated: Apr 16, 2026

Transplantation Into the Mouse Ovarian Fat Pad
Published on: September 7, 2016
Ovarian masses: changing clinico histopathological trends
So Sharadha1, T A Sridevi2, T K Renukadevi2
1Department of Obstetrics and Gynecology, ESIC Medical College and PGIMSR, K.K.Nagar, Chennai, 600078 TamilNadu India.
Objective:
To study the clinical and histopathological presentation of ovarian masses.
Method:
Retrospective analysis of 205 cases from May 2009 to June 2013.
Results:
Incidence of ovarian masses was 6.9 %. Among 205 cases, 68 % were neoplastic. Among the neoplasms, 87.8 % were benign, 10 % malignant, and 2.2 % borderline. Mean ages of malignant and benign neoplasm were 41 and 39 years, respectively. 42.9 % malignant tumors presented with non-specific abdominal and constitutional symptoms. Serous cystadenoma was the commonest benign tumor (67 %) followed by Mucinous (19 %) and Dermoid (11.6 %). Most common malignant ovarian tumor was Serous cystadenocarcinoma (42.9 %). Out of the malignant cases, all were primary except one secondary deposit from Non-Hodgkin's Lymphoma. Only 28.6 % presented at stage I, remaining presented at stage III/IV.
Conclusion:
Ovarian neoplasms have twice the incidence of non-neoplasms. Mean age of malignant tumors is decreased. Rising trend in Mucinous cystadenoma is noted.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Ovaries
On the ovarian surface, a layer of...
Oogenesis
Ovarian Cycle

